Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Factorial, Multicentric, Randomized Clinical Trial of Remdesivir and Immunotherapy in Combination With Dexamethasone for Moderate COVID-19 (the AMMURAVID Trial)

NCT04832880 is registered in ClinicalTrials.gov with ASST Fatebenefratelli Sacco as lead sponsor.

NCT NCT04832880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04832880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Factorial, Multicentric, Randomized Clinical Trial of Remdesivir and Immunotherapy in Combination With Dexamethasone for Moderate COVID-19 (the AMMURAVID Trial)
Lead sponsor
ASST Fatebenefratelli Sacco
Phase
Phase 3
Overall status
Unknown status
Start date
April 6, 2021
Completion date
December 31, 2022
Enrollment
4,000 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

covid19